awmsg logo



glycopyrronium bromide (Assicco®)


Reference No. 2530

Publication date:
25/09/2014


Appraisal information

glycopyrronium bromide (Assicco®) 1 mg tablet
glycopyrronium bromide (Assicco®) 2 mg tablet


Company: Morningside Healthcare Ltd
BNF category: Gastro-intestinal system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 24/09/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, glycopyrronium bromide cannot be endorsed for use within NHS Wales for use in adults as add-on therapy in the treatment of peptic ulcer.
Statement of Advice (SOA)
Download